Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10915763rdf:typepubmed:Citationlld:pubmed
pubmed-article:10915763lifeskim:mentionsumls-concept:C0001779lld:lifeskim
pubmed-article:10915763lifeskim:mentionsumls-concept:C1419249lld:lifeskim
pubmed-article:10915763lifeskim:mentionsumls-concept:C0752121lld:lifeskim
pubmed-article:10915763lifeskim:mentionsumls-concept:C1444754lld:lifeskim
pubmed-article:10915763lifeskim:mentionsumls-concept:C0205341lld:lifeskim
pubmed-article:10915763lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:10915763lifeskim:mentionsumls-concept:C2827666lld:lifeskim
pubmed-article:10915763lifeskim:mentionsumls-concept:C0332162lld:lifeskim
pubmed-article:10915763pubmed:issue12lld:pubmed
pubmed-article:10915763pubmed:dateCreated2000-10-27lld:pubmed
pubmed-article:10915763pubmed:abstractTextSpinocerebellar ataxia type 2 (SCA2) is an autosomal dominant disorder caused by the expansion of a polymorphic (CAG)(n) tract, which is translated into an expanded polyglutamine tract in the ataxin-2 protein. Although repeat length and age at disease onset are inversely related, approximately 50% of the age at onset variance in SCA2 remains unexplained. Other familial factors have been proposed to account for at least part of this remaining variance in the polyglutamine dis-orders. The ability of polyglutamine tracts to interact with each other, as well as the presence of intra-nuclear inclusions in other polyglutamine disorders, led us to hypothesize that other CAG-containing proteins may interact with expanded ataxin-2 and affect the rate of protein accumulation, and thus influence age at onset. To test this hypothesis, we used step-wise multiple linear regression to examine 10 CAG-containing genes for possible influences on SCA2 age at onset. One locus, RAI1, contributed an additional 4.1% of the variance in SCA2 age at onset after accounting for the effect of the SCA2 expanded repeat. This locus was further studied in SCA3/Machado-Joseph disease (MJD), but did not have an effect on SCA3/MJD age at onset. This result implicates RAI1 as a possible contributor to SCA2 neurodegeneration and raises the possibility that other CAG-containing proteins may play a role in the pathogenesis of other polyglutamine disorders.lld:pubmed
pubmed-article:10915763pubmed:languageenglld:pubmed
pubmed-article:10915763pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10915763pubmed:citationSubsetIMlld:pubmed
pubmed-article:10915763pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10915763pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10915763pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10915763pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10915763pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10915763pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10915763pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10915763pubmed:statusMEDLINElld:pubmed
pubmed-article:10915763pubmed:monthJullld:pubmed
pubmed-article:10915763pubmed:issn0964-6906lld:pubmed
pubmed-article:10915763pubmed:authorpubmed-author:HayesSSlld:pubmed
pubmed-article:10915763pubmed:authorpubmed-author:RieszTTlld:pubmed
pubmed-article:10915763pubmed:authorpubmed-author:RouleauG AGAlld:pubmed
pubmed-article:10915763pubmed:authorpubmed-author:PulstS MSMlld:pubmed
pubmed-article:10915763pubmed:authorpubmed-author:GasparCClld:pubmed
pubmed-article:10915763pubmed:authorpubmed-author:RanumL PLPlld:pubmed
pubmed-article:10915763pubmed:authorpubmed-author:TureckiGGlld:pubmed
pubmed-article:10915763pubmed:authorpubmed-author:Lopes-CendesI...lld:pubmed
pubmed-article:10915763pubmed:authorpubmed-author:BriseboisKKlld:pubmed
pubmed-article:10915763pubmed:issnTypePrintlld:pubmed
pubmed-article:10915763pubmed:day22lld:pubmed
pubmed-article:10915763pubmed:volume9lld:pubmed
pubmed-article:10915763pubmed:ownerNLMlld:pubmed
pubmed-article:10915763pubmed:authorsCompleteYlld:pubmed
pubmed-article:10915763pubmed:pagination1753-8lld:pubmed
pubmed-article:10915763pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10915763pubmed:meshHeadingpubmed-meshheading:10915763...lld:pubmed
pubmed-article:10915763pubmed:meshHeadingpubmed-meshheading:10915763...lld:pubmed
pubmed-article:10915763pubmed:meshHeadingpubmed-meshheading:10915763...lld:pubmed
pubmed-article:10915763pubmed:meshHeadingpubmed-meshheading:10915763...lld:pubmed
pubmed-article:10915763pubmed:meshHeadingpubmed-meshheading:10915763...lld:pubmed
pubmed-article:10915763pubmed:meshHeadingpubmed-meshheading:10915763...lld:pubmed
pubmed-article:10915763pubmed:meshHeadingpubmed-meshheading:10915763...lld:pubmed
pubmed-article:10915763pubmed:meshHeadingpubmed-meshheading:10915763...lld:pubmed
pubmed-article:10915763pubmed:meshHeadingpubmed-meshheading:10915763...lld:pubmed
pubmed-article:10915763pubmed:meshHeadingpubmed-meshheading:10915763...lld:pubmed
pubmed-article:10915763pubmed:year2000lld:pubmed
pubmed-article:10915763pubmed:articleTitleCAG repeat length in RAI1 is associated with age at onset variability in spinocerebellar ataxia type 2 (SCA2).lld:pubmed
pubmed-article:10915763pubmed:affiliationDepartment of Biology, Centre for Research in Neurosciences and Douglas Hospital Research Institute, McGill University, Montreal, Quebec H3G 1A4, Canada.lld:pubmed
pubmed-article:10915763pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10915763pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:10743entrezgene:pubmedpubmed-article:10915763lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10915763lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10915763lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10915763lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10915763lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10915763lld:pubmed